$29M Grant Powers 15 Cancer Breakthroughs at UQ

Australian researchers are about to accelerate the fight against some of humanity's toughest health challenges, thanks to a major funding win that will support bold new approaches to cancer, chronic disease, and mental health.

The University of Queensland announced that 15 of its scientists have collectively received $29 million from the National Health and Medical Research Council. This isn't just another research grant—it's a green light for innovative programs that could transform how we treat aggressive brain tumors, prevent chronic pain after car accidents, and help people with treatment-resistant schizophrenia.

The funded projects span an impressive range. Dr. Rosemary Cater is developing a drug that literally starves brain cancer cells by blocking the nutrients they need to grow. Dr. Run Zhang is creating an ultrasound-based treatment using nano-sized particles to kill tumors deep inside the body, focusing on hard-to-treat liver cancers.

Other researchers are tackling problems that affect everyday Australians in profound ways. Professor Michele Sterling will test early treatments to prevent chronic pain after road crashes, potentially helping thousands avoid long-term disability. Dr. Natasha Reid is building Australia's first national system to identify and support people with fetal alcohol spectrum disorder, ensuring more timely and culturally safe care.

Some projects aim to make existing treatments work better. Dr. Changkui Fu is making cancer immunotherapy safer by reducing harmful immune reactions while improving how it reaches the spleen, where crucial immune cells activate. Dr. Fekade Sime is helping more patients receive antibiotic therapy safely at home instead of in hospitals, making serious infection treatment more accessible.

The beauty of these Investigator Grants is that they free researchers from the exhausting cycle of constant grant applications. Scientists can focus on the work itself, building collaborations and responding quickly to emerging priorities instead of drowning in paperwork.

The Ripple Effect

These 15 programs will create waves far beyond the lab. Dr. Dan Siskind is leading Australia's first National Clinical Trial Consortium for treatment-resistant schizophrenia, which will shape global treatment guidelines. Dr. Nicole Warrington's work on how genes influence disease progression could help doctors identify at-risk patients earlier and intervene before conditions worsen.

Professor Xiwang Zhang is investigating new technologies to rapidly extract life-saving proteins from human plasma, which could improve treatment supply for people with immune deficiencies, bleeding disorders, and neurological diseases. Dr. Joshua Tobin's personalized immune therapies for follicular lymphoma could help patients stay in remission longer without repeated treatments.

The funding supports researchers at all career stages, from emerging scientists like Dr. Sabrina Sofia Burgener studying liver enzymes to established leaders like Professor Robert Parton investigating how breast cancer cells survive under stress.

From preventing pain to personalizing cancer treatment, these Australian researchers are building a healthier future one breakthrough at a time.